Cargando…
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
Currently, the involvement of the endocannabinoid system in cancer development and possible options for a cancer-regressive effect of cannabinoids are controversially discussed. In recent decades, a number of preclinical studies have shown that cannabinoids have an anticarcinogenic potential. Theref...
Autores principales: | Ramer, Robert, Schwarz, Rico, Hinz, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520667/ https://www.ncbi.nlm.nih.gov/pubmed/31143113 http://dx.doi.org/10.3389/fphar.2019.00430 |
Ejemplares similares
-
The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
por: Ramer, Robert, et al.
Publicado: (2021) -
Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022) -
Endocannabinoid Modulation of Dopaminergic Motor Circuits
por: Morera-Herreras, Teresa, et al.
Publicado: (2012) -
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain
por: Toguri, James T., et al.
Publicado: (2016) -
Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells
por: Wittig, Felix, et al.
Publicado: (2023)